— Know what they know.
Not Investment Advice

CGON NASDAQ

CG Oncology, Inc. Common stock
1W: -7.1% 1M: -7.6% 3M: +12.1% YTD: +54.6% 1Y: +143.2%
$64.25
-0.34 (-0.53%)
 
Weekly Expected Move ±5.9%
$59 $63 $67 $71 $75
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 32 · $5.7B mcap · 59M float · 2.06% daily turnover · Short 70% of daily vol

📊 Key Metrics

TTM
$5M
Revenue
+666.0% YoY
$-187M
Net Income
-76.9% YoY
$-160M
Free Cash Flow
-95.1% YoY
-173.5%
Gross Margin
-6130.1%
Op. Margin
-5558.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-25.1%
ROA-24.2%
ROIC-972.2%

Valuation

P/E-29.1
P/B5.0
EV/EBITDA-26.1

Leverage

Debt/Equity0.01
Current Ratio24.63
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z87.66
Beneish M64.54

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms